Cineplex (TSX:CGX) Stock: Buy or Sell at $10?

The coronavirus vaccine will make way for a recovery of sorts in 2021, with undervalued Cineplex stock leading the way higher.

| More on:
movies, theatre, popcorn

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Cineplex (TSX:CGX) stock has been through a lot in 2020, as the coronavirus took us hostage. Cineplex was, in fact, one of the hardest-hit stocks. Nine months after the TSX market crash, it remains in the dumps. So, what should investors do with Cineplex stock now?

Surely, 2021 won’t be like 2020 and the coronavirus vaccine will make it a drastically different year. Every hospital, company, and person will feel this difference. So, without further ado, let’s take a closer look at the best course of action for Cineplex stock.

The decision to buy or sell

Whenever we think about what to do with a stock, we often think we have three options: buy, sell, or hold. Notice in the title of this article that I don’t mention hold. This is by design. “Hold” is a misleading course of action. It’s almost a way to avoid the question. It’s a call to do nothing.

But if we recommend a hold, aren’t we saying the stock is a buy? Maybe it’s a way to call it a buy, while also reflecting our uncertainty. But we need an actionable recommendation. The better way to think about it is as follows: If you didn’t own the stock, would you buy it? If you own the stock, will you sell it?

Should you buy or sell Cineplex stock?

Cineplex stock is down 70% since March. Unlike many other stocks, it has not recovered at all in 2020. But it’s 2021 now. This will be a year of rebuilding. It will probably take many of us by surprise. And that’s okay, because it’s naturally difficult to see through all the pain. The health and economic distress continue to build at this time.

In order to make a decision on Cineplex, we need to try to see through this second wave of the coronavirus. And now we can reasonably do this. The coronavirus vaccine is being rolled out. Every day that goes by, we are getting closer and closer to the end of the crisis.

The good news with regard to Cineplex stock is simple. It’s not pricing in anything related to a recovery. The bar is low. Expectations are low. Investors may be counting it out as a goner. But Cineplex is backed by a lot. Its brand and loyalty program. Its online businesses. And its share of Canada’s entertainment industry.

Cineplex stock is trading below $10. At this price, the movie exhibition industry doesn’t need to go back to what is was for investors to make a solid return.

Motley Fool: The bottom line

Cineplex stock sure presents investors with a dilemma. On the one hand, it’s clearly heading for bankruptcy, right? On the other hand, it has had a lot of staying power through this crisis. With the help of the government and cost cuts, maybe Cineplex can make it. And if it does make it, Cineplex stock will provide investors with very lucrative returns.

So, the choice is clear. Only investors who have extra money to invest in a such risky venture should buy Cineplex stock. Those who buy will likely benefit from a 2021 comeback, as the coronavirus vaccine leads an economic recovery.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Coronavirus

Business success with growing, rising charts and businessman in background
Coronavirus

1 Growth Stock Every Canadian Investor Should Consider Right Now

This growth stock saw shares pop 10% on June 20, as one analyst stated there is a significant opportunity to…

Read more »

Aircraft wing plane
Coronavirus

Bombardier Stock Merge: What it Means for Investors

Bombardier (TSX:BBD.B) stock went through a reverse stock split on June 13, turning 25 shares into one in one swift…

Read more »

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »